intelligence360
  • SUBSCRIBE
  • About us
  • Video News Daily
  • Contact Us
  • Search Icon

intelligence360

The Intelligent News Source

Posterity Health Secures $13M Series A to Expand Essential Male Reproductive Care

Posterity Health Secures $13M Series A to Expand Essential Male Reproductive Care

February 27, 2025 Craig Etkin

Dr. William Schoolcraft, Global Fertility Pioneer, Joins as Strategic Advisor

February 18, 2025 01:00 PM Eastern Standard Time

DENVER–(BUSINESS WIRE)–Posterity Health, the leader in male reproductive and hormonal health, has secured $13 million in Series A funding to expand access to comprehensive care for men nationwide. The round was led by Georgetown Equity Partners, with participation from existing investors FCA Venture Partners, Distributed Ventures, and WVV. New investors include SteelSky Ventures, the largest women’s health fund, as well as Scrub Capital and other digital health leaders.

“Male reproductive health remains one of the most underserved and poorly understood areas within healthcare. This funding gives us the opportunity to serve more men and their families.” – Pam Pure, CEO and co-founder, Posterity HealthPost this

Posterity Health provides innovative solutions to address fertility challenges, optimize hormone levels, and manage long-term health risks, combining cutting-edge technology with expert clinical care. Through its telehealth services, at-home diagnostics, and in-person care, the company has become a trusted partner for men at every stage — from family building and fertility optimization to hormone management, vasectomies, low-testosterone treatments, and more.

A recent actuarial analysis confirmed that for every $1 spent on male fertility care, employers save $2.30 in female fertility treatment costs. With 50% of all infertility cases linked to the male partner, traditional care models often delay male evaluation for nearly two years, leading to unnecessary treatments, missed diagnoses, and higher costs.

“I’ve committed my career to male reproductive health because it remains one of the most underserved and poorly understood areas within healthcare,” said Pam Pure, the CEO and Co-Founder of Posterity Health. “This funding gives us the opportunity to serve more men and their families, and it also demonstrates that the tide is turning and that men are starting to take a more active role in their own health. I’m proud to be part of that change.”

Closing Gaps in Male Reproductive Health

Posterity Health’s platform addresses longstanding challenges in male reproductive care, including:

  • Delayed Diagnoses & High Costs: Many couples struggling with infertility wait nearly two years before the male partner is tested, resulting in unnecessary procedures and financial strain. Personalized insights help identify male fertility issues earlier, leading to faster, more effective interventions.
  • Limited Access to Specialists: With only 250 fellowship-trained reproductive urologists nationwide, long wait times and geographic barriers often prevent men from receiving timely, evidence-based care. Posterity Health’s technology-driven triage system helps match patients to the right specialists, optimizing provider availability.
  • Overprescription & Mismanagement of Testosterone Therapy: Without proper oversight, hormone treatments can negatively impact fertility, yet they are often prescribed without a full understanding of their effects. Expert care coupled with advanced decision-support tools ensure appropriate hormone management based on clinical guidelines.
  • Undiagnosed Health Risks: Male infertility is linked to testicular cancer, high blood pressure, obesity, and other serious conditions, making early evaluation critical for long-term health. Posterity Health leverages data-driven tools to detect potential underlying health risks early, allowing for preventive care interventions.

“We are proud to partner with Posterity Health as they transform male reproductive care, improving outcomes for both men and women,” said Maria Toler, Founding & Managing Partner at SteelSky Ventures. “Women’s health doesn’t exist in a silo — male reproductive health is an essential part of the equation. By addressing male fertility earlier, we can reduce unnecessary, invasive treatments for women and help couples navigate the fertility journey more efficiently — saving time, money, and stress while improving success rates for couples trying to conceive.”

Dr. William Schoolcraft Joins as Strategic Advisor

Dr. William Schoolcraft, a global pioneer in fertility treatment, will serve as a Strategic Advisor to Posterity Health. Dr. Schoolcraft, who is widely regarded as a leading authority in fertility care, will lead efforts to educate clinicians and the public on the importance of early male fertility evaluation.

Dr. Schoolcraft has been instrumental in advancing fertility treatments, including breakthroughs in IVF and sperm quality optimization. He has authored numerous peer-reviewed scientific articles and is recognized internationally for his expertise. “Treating the male partner will avoid unnecessary female care, improve sperm quality, and even identify underlying health conditions like testicular cancer,” said Dr. Schoolcraft. “I am excited about the opportunity to team with Posterity Health to shift the burden of care from the female, provide a more equitable fertility process, and improve IVF success rates.”

The Future of Male Reproductive Care

With nationwide access, personalized insights, and a growing team of reproductive urologists, Posterity Health is pioneering a new era of male fertility and hormone care. Employers, payers, and health systems recognize the cost-saving and health-improving potential of early male fertility intervention, making Posterity Health the trusted partner in this evolving space.

“We see powerful benefits to females who are given the opportunity to manage their reproductive journey from pre-conception to menopause, and we believe that males deserve and are seeking out the same proactive care,” said Rebecca Mitchell, M.D., Managing Partner of Scrub Capital. “We are excited to support the team at Posterity Health as they promote digital, evidence-based male programs.”

This funding will allow Posterity Health to continue scaling its platform and expanding its reach, ensuring that every man has access to high-quality reproductive care at every stage of life.

For more information, visit posterityhealth.com.

Helpful Links

  • Read the Posterity Health Blog
  • Follow Posterity Health on LinkedIn
  • Follow Posterity Health on Instagram
  • Follow Posterity Health on Facebook
  • Follow Posterity Health on X

About Posterity Health

Posterity Health is the leader in male reproductive and hormonal health. We provide innovative solutions to address fertility challenges, optimize hormone levels, provide vasectomies and vasectomy reversals, and manage long-term health risks, combining cutting-edge technology with expert clinical care. Through our telehealth services, at-home diagnostics, and in-person care, Posterity Health is the trusted partner for men at every stage.

Contacts

Media Contact
Alexandra Grigsby
Marketing
alexandra@posterityhealth.com

(c)2025 Business Wire, Inc., All rights reserved.


Venture Capital
Business Wire, Colorado, Denver, Posterity Health, Venture Capital

Post navigation

NEXT
Glassbox Raises $1.2M to Reimagine the Spreadsheet for AI-Enabled Corporate Transactions
PREVIOUS
MAIA Biotechnology Announces Private Placement of $2,715,000
Comments are closed.
Subscribe for FREE!

intelligence360

intelligence360
Source: http://go.intelligence360.io/ and https://intelligence360.news/

Kimberly-Clark Corporation, one of the world's leading manufacturers of personal care and hygiene products, will establish an $800 million advanced manufacturing facility in Trumbull County, bringing an anticipated 491 new high-quality jobs. For Kimberly-Clark, this new facility would be its first in Ohio and represents not just a strategic expansion, but a decisive step in doubling down on growth in the American market. Spread across more than one million square feet, the Warren facility will provide the manufacturing capacity needed to unleash future growth for Kimberly-Clark’s fastest-growing personal care categories that include Baby & Child Care and Adult & Feminine Care. Warren is in geographic proximity to roughly 117 million consumers and will serve as a strategic hub for the Northeast and Midwest regions. Construction is expected to begin this month and will take up to two years.

In a statement Tamera Fenske, chief supply chain officer at Kimberly-Clark said, “Our investment in Warren is a pivotal step forward in our North America business and strategy.” “By establishing a new, state-of-the-art manufacturing facility in Ohio, we’re enhancing our ability to serve millions of consumers across the Midwest and Northeast with greater speed, agility, and resilience. It’s a once-in-a-career opportunity to build a facility from the ground up that reflects the future of manufacturing, and with the support of local partners like JobsOhio, the Department of Development, Lake to River, Western Reserve Port Authority, and local governments, we have the unique opportunity to create high-quality jobs and long-term economic impact in the region.”

Based in Dallas and employing 46,000 people in 34 countries, the company’s portfolio of brands also includes Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Andrex, Pull-Ups, GoodNites, Intimus, Plenitud, Sweety, Softex, Viva and WypAll. Its products are sold in more than 175 countries and territories.
Source: http://go.intelligence360.io/ and https://intelligence360.news/

Snorkel AI announced general availability of two new product offerings on the Snorkel AI Data Development Platform: Snorkel Evaluate and Snorkel Expert Data-as-a-Service. These launches advance its mission to turn knowledge into specialized AI—helping teams move from prototype to production at scale by leveraging Snorkel AI’s programmatic data development technology. In addition, Snorkel AI announced it has raised $100 million in Series D funding at a $1.3 billion valuation, led by Addition. This new funding will fuel continued research and innovation in evaluating and tuning specialized AI systems with expert data.


In a statement Alex Ratner, Co-founder and CEO of Snorkel AI said, “We are seeing a surge of momentum around agentic AI, but specialized enterprise agents aren’t ready for production in most settings.” “Enterprises need domain-specific data and expertise to make this a reality. We’re excited to deliver on this need and help AI innovators develop expert data to bring their LLM and agentic systems into production with our new offerings, which round out Snorkel’s unified AI data development stack.”

Snorkel AI is building the Snorkel AI Data Development Platform for evaluating and tuning specialized AI at scale. Snorkel AI’s offerings, including Snorkel Evaluate and Snorkel Expert Data-as-a-Service, accelerate evaluation and tuning of specialized AI systems with expert data—helping teams move from prototype to production at scale by leveraging Snorkel AI’s programmatic data development technology. Launched out of the Stanford AI Lab, Snorkel AI’s platform is used in production by Fortune 500 companies, including BNY, Wayfair, and Chubb, as well as across the U.S. federal government, including the U.S. Air Force.
Source: http://go.intelligence360.io/ and https://intelligence360.news/

TicketManager, a global leader in event ticket and guest management solutions for the corporate enterprise, today announced Valeas Capital Partners, a growth-oriented private-equity firm, has acquired a majority stake in the company. Under the terms of the agreement, Valeas is committing $110 million to support TicketManager’s strategic growth plans. TicketManager Co-Founder and CEO Tony Knopp and COO Ken Hanscom will retain a minority interest in the Company. Founded in 2007, TicketManager is the category leader in providing software and services to manage end-to-end event ticket workflow and guest experiences. Serving as the central hub and system of record for data-driven organizations, the platform streamlines every step of the ticket management process. Every year, companies spend more than $600 billion on customer entertainment, yet 43% of corporate tickets are never used and fewer than 20% of organizations leverage modern software to optimize those investments and mitigate compliance risk.

In a statement Tony Knopp, CEO and Co-Founder of TicketManager said, “Live events are an important investment for businesses of all sizes. Whether major global sponsorships, naming rights for stadiums, luxury suites or even a few season tickets for the local team, companies use them to attract and keep customers while building their brands. But in today’s market, many companies struggle with growing pressure to show the value of their ticket spending.” “We knew there was a better way, and that’s why we created TicketManager – to make company tickets easy and prove the return on investment with cutting edge technology and services.”

TicketManager is a leading event- and guest-management platform that empowers companies to make client entertainment easy and drive greater return on investment. It offers convenient and simple technology to manage corporate sports and entertainment tickets, create exceptional guest life-cycle experiences, and measure effectiveness. TicketManager is trusted by more than 500 global brands including Verizon, FedEx, Adidas, Anheuser-Busch, and Mastercard.
Load More... Subscribe

Categories

Recent Posts

  • Bespoken Spirits Announces Successful Close of Series-C Funding Round June 9, 2025
  • Bito Raises $5.7M Seed Extension to Expand AI Code Review Platform with Codebase Awareness June 9, 2025
  • Pillar Biosciences Raises $34.5M in Funding June 9, 2025
  • CloudZero Raises $56M Series C To Redefine Cloud Cost Optimization In The AI Era June 9, 2025

Archives

© 2025   Copyright SI360 Inc. All Rights Reserved.